The FDA holds a public meeting on biosimilars

Public Hearing on the FDA’s approach to enhancing competition and innovation in the biological products marketplace, including by facilitating greater availability of biosimilar and interchangeable products will be held at the FDA Silver Spring, MD offices on September 4 at 9 am. Webcast Link: https://collaboration.fda.gov/biosimilarspart15

https://thefly.com/landingPageNews.php?id=2785103